{"organizations": [], "uuid": "4bef4722b044a1361d5ae1904fdef18c52b5d7e4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-obalon-announces-termination-of-pu/brief-obalon-announces-termination-of-public-offering-of-common-stock-idUSASB0C1X2", "country": "US", "domain_rank": 408, "title": "BRIEF-Obalon Announces Termination Of Public Offering Of Common Stock", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-23T16:31:00.000+02:00", "replies_count": 0, "uuid": "4bef4722b044a1361d5ae1904fdef18c52b5d7e4"}, "author": "", "url": "https://www.reuters.com/article/brief-obalon-announces-termination-of-pu/brief-obalon-announces-termination-of-public-offering-of-common-stock-idUSASB0C1X2", "ord_in_thread": 0, "title": "BRIEF-Obalon Announces Termination Of Public Offering Of Common Stock", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "ering of common stock reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "obalon therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 23, 2018 / 2:31 PM / Updated 23 minutes ago BRIEF-Obalon Announces Termination Of Public Offering Of Common Stock Reuters Staff \nJan 23 (Reuters) - Obalon Therapeutics Inc: \n* OBALON ANNOUNCES TERMINATION OF PUBLIC OFFERING OF COMMON STOCK \n* OBALON THERAPEUTICS- TERMINATION OF UNDERWRITING AGREEMENT,CANCELLATION OF PREVIOUSLY ANNOUNCED OFFERING OF 5.5 MILLION SHARES AT PRICE OF $5.50/SHARE \n* OBALON - PURPORTED WHISTLEBLOWER CONTACTED CO‘S INDEPENDENT AUDITORS TO ALLEGE “IMPROPER REVENUE RECOGNITION” IN FISCAL Q4 \n* OBALON - ALLEGATIONS BY PURPORTED WHISTLEBLOWER WERE REPORTED TO CO LATE ON JAN. 22 \n* OBALON -‍CO‘S AUDIT COMMITTEE TO OVERSEE AN INTERNAL INVESTIGATION OF ALLEGATIONS RELATING TO ALLEGEDLY “IMPROPER REVENUE RECOGNITION” DURING Q4 2017 \n* OBALON - REPORTING ALLEGATIONS TO CO ON JAN. 22 MADE IT “INFEASIBLE” TO COMPLETE INVESTIGATION BEFORE INTENDED CLOSING OF PUBLIC OFFERING \n* OBALON - DOESN‘T CURRENTLY BELIEVE MATERIAL ADJUSTMENTS TO PRELIM, UNAUDITED REVENUE FOR Q4 2017, FY2017 REPORTED WILL BE REQUIRED DUE TO ALLEGATIONS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-23T16:31:00.000+02:00", "crawled": "2018-01-23T16:56:20.001+02:00", "highlightTitle": ""}